16 clinical trials found.
-
MICROBiome Involvement in Outcomes of Methotrexate Efficacy-RA
This is a prospective, observational, proof-of-principle, open-label, single-blinded study looking at the effects of the gut microbiome on the metabolism and response to methotrexate treatment ...Phase N/A
TRIAL ROLE: Principal Investigator
-
THE ROLE OF THE MICROBIOME IN MONOZYGOTIC TWINS WITH PSORIASIS AND PSORIATIC ARTHRITIS
We propose a longitudinal study of monozygotic twins discordant for psoriatic disease. Subjects will be characterized with detailed clinical questionnaires in addition to blood, fecal ...Phase N/A TRIAL ROLE: Principal Investigator
-
Serologic Testing and Genomic Analysis of Autoimmune Immune-Mediated and Rheumatic Patients with COVID-19 (SAGA)
This is a prospective cohort study involving all subjects enrolled in the Web-based Assessment of Autoimmune, Immune-Mediated, and Rheumatic Patients during the COVID-19 Pandemic (WARCOV ...Phase N/A TRIAL ROLE: Principal Investigator
-
Preventing Arthritis in a Multi-Center Psoriasis At-Risk Cohort (Multi-Center PAMPA Study)
This is a multi-center (North-America), randomized, double-blind, placebo-controlled, wait-list, interventional, preventive trial of guselkumab in high-risk psoriasis patients compared to non-biologic standard of care. Population ...Phase
TRIAL ROLE: Principal Investigator
-
Psoriatic Response and Onset: Genes Radiology Environment Skin and Synovium)
This is a longitudinal, observational cohort study to aimed to understand the clinical and biologic underpinnings of psoriasis and psoriatic arthritis development and severity. To ...Phase N/A TRIAL ROLE: Principal Investigator
-
A pilot proof of concept study of the Effects of Administration of SCFA in Rheumatoid Arthritis Inadequate Responders (EASi-RAIR)
This study is a pilot, proof of concept study to determine the effects of administering an oral SCFA supplement to RA patients with inadequate response ...Phase
TRIAL ROLE: Principal Investigator
-
ELLIPSS: ELucidating the Landscape of Immunoendotypes in Psoriatic Skin and Synovium
The goal of Accelerating Medicines Partnership (AMP) is to better understand and develop new treatments for autoimmune disorders (such as Psoriatic Spectrum Disease (PSD)), and ...Phase N/A TRIAL ROLE: Principal Investigator
-
Accelerating Medicines Partnership: Autoimmune and Immune-Mediated Disease (AIM) Rheumatoid Arthritis
The goal of AMP is to develop new treatments for autoimmune disorders (such as RA), and to reduce the time and cost of developing these ...Phase N/A TRIAL ROLE: Principal Investigator
-
Rheumatology SAMPLE (Specimen And Matched Phenotype Linked Evaluation) Registry and Biorepository
In this research proposal, we will develop a clinical registry containing information related to the patient’s ethnicity, race, gender, age, medications, specific disease or ...Phase N/A TRIAL ROLE: Sub Investigator
-
Clinical Histopathologic Immunochemical Biochemical and Molecular Analysis of Blood Synovium and Synovial Fluid from Patients with Arthritis
Clinical Histopathologic, Immunochemical, Biochemical, and Molecular Analysis of Blood, Synovium, and Synovial Fluid from Patients with ArthritisPhase N/A TRIAL ROLE: Sub Investigator
